洽洽食品(002557.SZ):2020年度擬繼續申請總額不超15億元的綜合授信額度
格隆匯4月8日丨洽洽食品(002557.SZ)公佈,公司第四屆董事會第二十七次會議召開,審議通過了公司《關於申請2020年度銀行綜合授信額度的議案》;
為滿足公司生產經營需要,提升公司經營效益,根據公司財務部對資金計劃的安排,結合公司財務狀況及經營業務的需求,公司2020年度擬繼續向商業銀行申請總額不超過15億元人民幣的綜合授信額度,以上授信自公司與銀行簽訂貸款合同之日起至2020年年度股東大會召開之日止,業務範圍包括但不限於流動資金貸款、承兑匯票、信用證、項目貸款等。
該議案尚需提交公司股東大會審議。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.